NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

But yet Optune achieved 13% nOS in a Phase 3 trial and has been approved in multiple indications in multiple countries. NWBO's Phase 3 trial resulted in virtually NO share gains whatsoever. Is still very uncertain in gaining any approval after a 16 year trial that burned over a BILLION dollars in shareholder money and has only made the CEO rich.